Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Liver Cancer
100%
BRAF mutation
100%
Metastatic Colorectal Cancer (mCRC)
100%
Surgically Treated
100%
Overall Survival
80%
Disease-free Survival
80%
Genotype
80%
V600E
80%
Colorectal Cancer Liver Metastasis (CRCLM)
80%
BRAF V600E mutation
60%
Hazard Ratio
40%
KRAS mutation
40%
V600E-BRAF
40%
Prognostic Determinants
40%
Resection
20%
Multivariable
20%
Aggressive Tumor
20%
Primary Tumor
20%
Mutational Status
20%
Cox Proportional Hazards Model
20%
Prognostic Factors
20%
Exclusion Criteria
20%
Right-sided
20%
Recurrence Risk
20%
Worse Prognosis
20%
Genotype Groups
20%
Curative Intent
20%
Tumor Biology
20%
Hepatectomy
20%
Wild-type KRAS
20%
Primary Colorectal Cancer
20%
Non-V600E
20%
Metachronous Liver Metastasis
20%
Strong Association
20%
Multivariate Cox Proportional Hazards Regression
20%
Recurrence after Resection
20%
BRAF Wild-type
20%
V600E mutation
20%
Medicine and Dentistry
Liver Cancer
100%
Overall Survival
100%
Recurrent Disease
100%
Disease Free Survival
100%
Colorectal Liver Metastasis
100%
Hazard Ratio
50%
Primary Tumor
25%
Proportional Hazards Model
25%
Cohort Analysis
25%
Prognostic Factor
25%
Hepatectomy
25%
Liver Metastasis
25%
Colorectal Carcinoma
25%
Tumor Biology
25%
Genetics
25%
Long-Term Outcome
25%
Nursing and Health Professions
Liver Cancer
100%
Overall Survival
100%
Recurrent Disease
100%
Disease Free Survival
100%
Colorectal Liver Metastasis
100%
Hazard Ratio
50%
Neoplasm
25%
Cohort Analysis
25%
Proportional Hazards Model
25%
Primary Tumor
25%
Liver Resection
25%
Wild Type
25%
Liver Metastasis
25%
Colorectal Carcinoma
25%
Biochemistry, Genetics and Molecular Biology
KRAS
100%
Genotyping
100%
Overall Survival
80%
Disease Free Survival
80%
Wild Type
20%
Genetics
20%
Cohort Study
20%
Immunology and Microbiology
Overall Survival
100%
Disease Free Survival
100%
Wild Type
25%
Colorectal Carcinoma
25%